Contraceptive Pills Companies

Lupin Limited (India) Received tentative FDA approval for its Drospirenone Tablets, 4 mg (a contraceptive pill), to market a generic equivalent of Slynd Tablets, 4 mg, of Exeltis USA Inc. in November 2022, increasing generic options and potentially lowering costs.

Gedeon Richter (Hungary) Launched Drovelis (estetrol (E4]/ drospirenone (DRSP)) as a combined oral contraceptive in the United Kingdom in October 2022, offering an alternative with potentially lower androgenic side effects.

Theramex (US) Acquired rights to Zoely®, a patented oral contraceptive from Merck & Co for an undisclosed amount in January 2020, expanding its portfolio and offering a progestin-only option with minimal side effects.

Bayer (Germany) Partnered with Planned Parenthood in August 2023 to offer free or low-cost birth control pills and other reproductive healthcare services to uninsured and underinsured individuals in the US, increasing accessibility for vulnerable populations.

Hespera Pharma (US) Announced clinical trial results in June 2023 for their novel once-monthly oral contraceptive pill, offering potential for improved convenience and adherence compared to daily regimens.

List of Contraceptive Pills Key Companies in the Market

• Sanofi S.A.


• Bayer Healthcare


• Janssen Pharmaceuticals Inc.


• Amneal Pharmaceuticals LLC


• Organon International


• Teva Pharmaceuticals


• Aurobindo Pharma Limited


• Abbvie Inc


• Johnson & Johnson


• Pfizer Inc.